Screener
Indivior Pharmaceuticals, Inc. INDV Business Segments — Investment Income, Interest
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s business segments — investment income, interest?
- Indivior Pharmaceuticals, Inc. (INDV) reported business segments — investment income, interest of $3M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s business segments — investment income, interest changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s business segments — investment income, interest decreased by 25.0% year-over-year, from $4M to $3M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s business segments — investment income, interest?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s business segments — investment income, interest has grown at a 5.0% compound annual growth rate (CAGR), from $19M to $22M.
- What does business segments — investment income, interest mean?
- Reflects the interest income earned on cash balances, short-term investments, or other financial assets held by the segment. It indicates the segment's ability to generate non-operating returns from its liquidity position.
Ask your AI about Indivior Pharmaceuticals, Inc.'s business segments — investment income, interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude